Thrombocytopenia in patients with severe acute respiratory syndrome (review)

Hematology

Volumn 10, Issue 2, 2005, Pages 101-105

  Yang, Mo ^a,b   Ng, Margaret H L ^a   Chi, Kong Li ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Coronavirus; Lymphopenia; SARS; Thrombocytopenia

Indexed keywords

GLUCOCORTICOID;

ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; COMORBIDITY; CORONAVIRUS; DISEASE ASSOCIATION; GROWTH INHIBITION; HUMAN; LUNG INJURY; LYMPHOCYTOPENIA; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; SEVERE ACUTE RESPIRATORY SYNDROME; THROMBOCYTOPENIA; VIRUS INFECTION; HEMATOPOIETIC STEM CELL; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOLOGY; LYMPHOCYTE COUNT; REVIEW; SARS CORONAVIRUS; VIROLOGY;

HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOCYTE COUNT; LYMPHOPENIA; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 24644433956     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330400026170     Document Type: Article

References (40)

1. Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003;361:1319-1325.
2. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-1966.
3. Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003;348:1995-2005.
4. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-1976.
5. Fouchier RA, Kuiken T, Schutten M, et al. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 2003;423:240.
6. Kuiken T, Fouchier RA, Schutten M, et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 2003;362:263-270.
7. Rota PA, Oberste MS, Monroe SS, et al. Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome. Science 2003;300:1394-1399.
8. Marra MA, Jones SJ, Astell CR, et al. The Genome Sequence of the SARS-Associated Coronavirus. Science 2003; 300:1399-1404.
9. Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348:1986-1994.
10. Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348:1977-1985.
11. Hon KLE, Leung CW, Cheng WTF, et al. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet 2003;361:1701-1703.
12. Wong RS, Wu A, To KF, Lee N, Lam CW, Wong CK, Chan PK, Ng MH, Yu LM, Hui DS, Tam JS, Cheng G, Sung JJ. Haematological manifestations in patients with severe acute respiratory syndrome: Retrospective analysis. BMJ 2003;326:1358-1362.
13. Choi KW, Chau TN, Tsang O, Tso E, Chiu MC, Tong WL, Lee PO, Ng TK, Ng WF, Lee KC, Lam W, Yu WC, Lai JY, Lai ST, Princess Margaret Hospital SARS Study Group. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med 2003;139(9):715-723, Nov 4.
14. Liu CL, Lu YT, Peng MJ, Chen PJ, Lin RL, Wu CL, Kuo HT. Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever. Chest 2004;126(2):509-517, Aug.
15. Lim HK, Liu CP, Huang FY, Kuu HT, Yang YC, Chen PJ, Lee CM, Chiu NC, Tseng HK. Severe acute respiratory syndrome in a medical center in Taipei. J Microbiol Immunol Infect 2003;36(3):161-168, Sep.
16. Jang TN, Yeh DY, Shen SH, Huang CH, Jiang JS, Kao SJ. Severe acute respiratory syndrome in Taiwan: Analysis of epidemiological characteristics in 29 cases. J Infect 2004;48(1):23-31, Jan.
17. Vu HT, Leitmeyer KC, Le DH, Miller MJ, Nguyen QH, Uyeki TM, Reynolds MG, Aagesen J, Nicholson KG, Vu QH, Bach HA, Plan AJ. Clinical description of a completed outbreak of SARS in Vietnam. Emerg Infect Dis 2004;10(2):334-338, February-May 2003.
18. Jolicoeur P, Lamontagne L. Impairment of bone marrow pre-B and B cells in MHV3 chronically-infected mice. Adv Exp Med Biol 1995;380:193-195.
19. Jolicoeur P, Lamontagne L. Impaired T and B cell subpopulations involved in a chronic disease induced by mouse hepatitis virus type 3. J Immunol 1994;153:1317-1318.
20. Yang J, Yang M, Xu F, Li K, Lee KM, Ng PC, Tam JS, Yuen PM, Fok TF. Effects of Oxygen-Induced Lung Damage on Megakaryocytopoiesis and Platelet Homeostasis in a Rat Model. Pediatr Res 2003;54(3):344-352, Sep.
21. Martin J, Slater DN, Trowbridge EA. Abnormal intrapulmonary platelet production: a possible cause of vascular and lung disease. Lancet 1983;1:793-796.
22. Collins AR. In vitro detection of apoptosis in monocytes/ macrophages infected with human coronavirus. Clin Diagn Lab Immunol 2002;9:1392-1395.
23. Yeager CL, Ashmun RA, Williams RK, et al. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 1992;357:420-422.
24. Kontoyiannis DP, Pasqualini R, Arap W. Aminopeptidase N inhibitors and SARS. Lancet 2003;361:1558.
25. Wentworth DE, Holmes KV. Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): Influence of N-linked glycosylation. J Virol 2001;75:9741-9752.
26. Hammarstrom S. The carcinoembryonic antigen (CEA) family: Structure, suggested function and expression in normal and malignant tissues. Semin Cancer Biol 1999; 9:67-81.
27. Yang M, Li CK, Ng MHL, Chan PKS, Li KKH, Lau KM, Pong NH, Tsang KS, Cheng G, Fok TF. The possible mechanisms of SARS associated thrombocytopenia. Blood Nov 16, 2003;102(11):538A-539A, 1976 Part 1.
28. Yang M, Li K, Chui CM, Yuen PM, Chan PK, Chuen CK, Li CK, Fok TF. Expression of interleukin (IL) 1 type I and type II receptors in megakaryocytic cells and enhancing effects of IL-1beta on megakaryocytopoiesis and NF-E2 expression. Br J Haematol 2000;111:371-380.
29. Yang M, Khachigian LM, Hicks C, Chesterman CN, Chong BH. Identification of PDGF receptors on human megakaryocytes and megakaryocytic cell lines. Thromb Haemost 1997;78:892-896.
30. Noiva R, Lennarz WJ. Protein disulfide isomerase. A multi-functional protein resident in the lumen of the endoplasmic reticulum. J Biol Chem 1992;267:3553-3556.
31. Ryser HJ, Levy EM, Mandel R, DiSciullo GJ. Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction. Proc Natl Acad Sci USA 1994; 91:4559-4563.
32. Gallina A, Hanley TM, Mandel R, et al. Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry. J Biol Chem 2002;277:50579-50588.
33. Scaradavou A. HIV-related thrombocytopenia. Blood Rev 2002;16:73-76.
34. Nardi M, Tomlinson S, Greco MA, Karpatkin S. Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia. Cell 2001;106:551-561.
35. Li T, Qiu Z, Han Y, Wang Z, Fan H, Lu W, Xie J, Ma X, Wang A. Rapid loss of both CD4(+) and CD8(+) T lymphocyte subsets during the acute phase of severe acute respiratory syndrome. Chin Med J (Engl) 2003; 116:985-987.
36. Tang X, Yin C, Zhang F, Fu Y, Chen W, Chen Y, Wang J, Jia W, Xu A. Measurement of subgroups of peripheral blood T lymphocytes in patients with severe acute respiratory syndrome and its clinical significance. Chin Med J (Engl) 2003;116:827-830.
37. Slade JD, Hepburn B. Prednisone-induced alterations of circulating human lymphocyte subsets. J Lab Clin Med 1983;101:479-487.
38. Cupps TR, Fauci AS. Corticosteroid-mediated immunoregulation in man. Imm Rev 1982;65:133-155.
39. Panesar NS. Lymphopenia in SARS. Lancet 2003;361:1985.
40. Thompson BT. Glucocorticoids and acute lung injury. Crit Care Med 2003;31:S253-S257.